SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018A 5 amino-acid insertion in the C-terminal region of HIV-2 integrase impacts phenotypic susceptibility to the five integrase inhibitors- Quentin Le HingratView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018Influence of resistance in the future- Richard Harrigan, MDView Slideset
PCPep CollMD, MSSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018The current status of PrEP in Europe- Pep Coll, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018The prevalence of resistance associated substitutes through Europe The European prevalence of hepatitis C virus NS5A polymorphisms- Stephanie PoppingView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018Is there a need for HCV resistance testing in routine diagnostics and patient treatment? - Routine HCV genotyping and resistance testing and performance of the Sentosa SQ HCV Genotyping v2.0 assaysing next-generation sequencing- Robert EhretView Slideset
DPDimitrios ParaskevisPhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018HIV transmission in the migrant population- Dimitrios Paraskevis, PhDView Slideset
PCPep CollMD, MSSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018Long acting HIV drugs for prevention: what are the data?- Pep Coll, MDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018How would the epidemic evolve in the future- David van de VijverView Slideset
OSOana SăndulescuMD, PhDSlidesetHIVViral Hepatitis and Liver DiseaseEuropean Meeting on HIV & Hepatitis 2018The HIV epidemic in CEE countries- Oana Săndulescu, MD, PhDView Slideset
SlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017NASH and NAFLD in HIV: same or different? - Mariana Machado, MDView Slideset
JRJürgen RockstrohMDSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017What challenges remain in viral hepatitis- Jürgen Rockstroh, MDView Slideset
NCNikoloz ChkhartishviliMD, MS, PhDSlidesetHIVViral Hepatitis and Liver DiseaseInternational Workshop on HIV & Hepatitis Co-infection 2017HCV elimination program in Georgia: Successes and challenges- Nikoloz Chkhartishvili, MD, MS, PhDView Slideset
